19F NMR study of the uptake of 2'-fluoro-5-methyl-β-L- arabinofuranosyluracil in erythrocytes: Evidence of transport by facilitated and nonfacilitated pathways

Biochemical Pharmacology

Volumn 55, Issue 10, 1998, Pages 1611-1619

  Xu, Arron S L ^a   Chu, Chung K ^b   London, Robert E ^a  

^a NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES   (United States)

^b UNIVERSITY OF GEORGIA   (United States)

Author keywords

2' fluoro 5 methyl L arabinofuranosyluracil; 19F NMR; Erythrocytes; Membrane transport; Nucleoside analogs

Indexed keywords

2' FLUORO 5 METHYL BETA LEVO ARABINOFURANOSYLURACIL; BUTANOL; CHLOROMERCURIBENZENESULFONIC ACID; DIPYRIDAMOLE; NITROBENZYLTHIOINOSINE; NUCLEOSIDE ANALOG; PAPAVERINE; UNCLASSIFIED DRUG; URACIL; 2'-FLUORO-5-METHYLARABINOSYLURACIL; ANTIVIRUS AGENT; CLEVUDINE; DRUG DERIVATIVE; FLUORINE; URACIL ARABINOSIDE;

ARTICLE; BINDING AFFINITY; CELL MEMBRANE PERMEABILITY; CELL MEMBRANE TRANSPORT; CHEMICAL MODIFICATION; COMPETITIVE INHIBITION; CONCENTRATION RESPONSE; DIFFUSION COEFFICIENT; ERYTHROCYTE MEMBRANE; HUMAN; HUMAN CELL; INHIBITION KINETICS; MEMBRANE FLUIDITY; MICHAELIS CONSTANT; NORMAL HUMAN; NUCLEAR MAGNETIC RESONANCE; NUCLEOSIDE TRANSPORT; PRIORITY JOURNAL; STRUCTURE ACTIVITY RELATION; TEMPERATURE SENSITIVITY; BLOOD; DRUG ANTAGONISM; ERYTHROCYTE; METABOLISM; NUCLEAR MAGNETIC RESONANCE SPECTROSCOPY; TRANSPORT AT THE CELLULAR LEVEL;

ANTIVIRAL AGENTS; ARABINOFURANOSYLURACIL; BIOLOGICAL TRANSPORT; DIPYRIDAMOLE; ERYTHROCYTES; FLUORINE; HUMANS; MAGNETIC RESONANCE SPECTROSCOPY;

EID: 0032523283     PISSN: 00062952     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0006-2952(98)00017-3     Document Type: Article

References (44)

1. De Clercq E. Potential drugs for the treatment of AIDS. J Antimicrob Chemother. 23:(Suppl A):1989;35-46.
2. Schalm SW, De Man RA, Heijtink RA, Niesters HG. New nucleoside analogs for chronic hepatitis B. J Hepatol. 22:(Suppl 1):1995;52-56.
3. Furman PA, Fyfe JA, St. Clair MH, Weinhold K, Rideout JL, Freeman GA, Lehrman SN, Bolognesi DP, Broder S, Mitsuya H, Barry DW. Phosphorylation of 3′-azido-3′-deoxythymidine and selective interaction of the 5′-triphosphate with human immunodeficiency virus reverse transcriptase. Proc Natl Acad Sci U S A. 83:1986;8333-8337.
4. Balzarini J. Metabolism and mechanism of antiretroviral action of purine and pyrimidine derivatives. Pharm World Sci. 16:1987;113-126.
5. Chang CN, Doong SL, Zhou JH, Beach JW, Jeong LS, Chu CK. Deoxycytidine deaminase-resistant stereoisomer is the active form of (±)-2′,3′-dideoxy-3′-thiacytidine in the inhibition of hepatitis B virus replication. J Biol Chem. 267:1992;13938-13942.
6. Zimmerman T, Mahony WB, Prus KL. 3′-Azido-3′-deoxythymidine. An unusual nucleoside analog that permeates the membrane of human erythrocytes and lymphocytes by nonfacilitated diffusion. J Biol Chem. 262:1987;5748-5754.
7. Domin BA, Mahony WB, Zimmerman TP. 2′,3′-Dideoxythymidine permeation of the human erythrocyte membrane by nonfacilitated diffusion. Biochem Biophys Res Commun. 154:1988;825-831.
8. Domin BA, Mahony WB, Zimmerman TP. Desciclovir permeation of the human erythrocyte membrane by nonfacilitated diffusion. Biochem Pharmacol. 42:1991;147-152.
9. Kraupp M, Marz R. Nucleobase and nucleoside transport in mammalian cells. Wien Klin Wochenschr. 107:1995;677-680.
10. Plagemann PGW, Wohlhueter RM, Woffendin C. Nucleoside and nucleobase transport in animal cells. Biochim Biophys Acta. 947:1988;405-443.
11. Zimmerman TP, Prus KL, Mahony WB, Domin BA. 3′-Azido-3′-deoxythymidine and acyclovir Antiviral nucleoside analogs with unusual cell membrane permeation properties . Karagi KM, Mishioka K, Kelley WN. Purine and Pyrimidine Metabolism in Man VI. Part B:1989;399-406 Plenum Press, New York.
12. Cheung AP, Kenney D. Partition coefficients and capacity factor of some nucleoside analogs. J Chrommatogr. 506:1990;119-131.
13. Cass CE, Paterson ARP. Mediated transport of nucleosides in human erythrocytes. J Biol Chem. 247:1972;3314-3320.
14. Cabantchik ZI, Ginsburg H. Transport of uridine in human red blood cells. J Gen Physiol. 69:1977;75-96.
15. Chu CK, Ma T, Shanmuganathan K, Wang C, Xiang Y, Pai SB, Yao GQ, Sommadossi JP, Cheng Y-C. Use of 2′-fluoro-5-methyl-β-L-arabinofuranosyluracil as a novel antiviral agent for hepatitis B virus and Epstein-Barr virus. Antimicrob Agents Chemother. 39:1995;979-981.
16. Pai SB, Liu S-H, Zhu Y-L, Chu CK, Cheng Y-C. Inhibition of hepatitis B virus by a novel L-nucleoside, 2′-fluoro-5-methyl-β-L-arabinofuranosyl uracil. Antimicrob Agents Chemother. 40:1996;380-386.
17. Yao G-Q, Liu S-H, Chou E, Kukhanova M, Chu CK, Cheng Y-C. Inhibition of Epstein-Barr virus replication by a novel L-nucleoside, 2′-fluoro-5-methyl-β-L-arabinofuranosyluracil. Biochem Pharmacol. 51:1996;941-947.
18. Bessis M, Lessin LS, Beutler E. Morphology of the erythron. Williams WJ, Beutler E, Erslev AJ, Lichtman MA. Hematology. 1983;231-237 McGraw-Hill Book Co. New York.
19. Savitz D, Sidel VW, Solomon AK. Osmotic properties of human red cells. J Gen Physiol. 48:1964;79-94.
20. Sha'afi RI, Rich GT, Sidel VW, Bossert W, Solomon AK. The effect of the unstirred layer on human red cell water permeability. J Gen Physiol. 50:1967;1377-1399.
21. Domin BA, Mahony WB, Koszalka GW, Porter DJT, Hajian G, Zimmerman TP. Membrane permeation characteristics of 5′-modified thymidine analogs. Mol Pharmacol. 41:1992;950-956.
22. Pickard MA, Brown RR, Paul B, Paterson AR. Binding of the nucleoside transport inhibitor 4-nitrobenzylthioinosine to erythrocyte membranes. Can J Biochem. 51:1973;666-672.
23. Kraupp M, Marz R. Membrane transport of nucleobases Interaction with inhibitors . Gen Pharmacol. 26:1995;1185-1190.
24. Kraupp M, Paskutti B, Schon C, Marz R. Inhibition of purine nucleobase transport in human erythrocytes and cell lines by papaverine. Biochem Pharmacol. 48:1994;41-47.
25. Domin BA, Mahony WB, Zimmerman TP. Transport of 5-fluorouracil and uracil into human erythrocytes. Biochem Pharmacol. 46:1993;503-510.
26. Gati WP, Misra HK, Knaus EE, Wiebe LI. Structural modifications at the 2′- and 3′-positions of some pyrimidine nucleosides as determinants of their interaction with the mouse erythrocyte nucleoside transporter. Biochem Pharmacol. 33:1984;3325-3331.
27. Kirk K. NMR methods for measuring membrane transport rates. NMR Biomed. 3:1990;1-16.
28. Kuchel PW, Kirk K, King GF. NMR methods for measuring membrane transport. Hilderson HJ, Ralston GB. Subcellular Biochemistry. Vol 23:1994;247-327 Plenum Press, New York.
29. 19F NMR using trifluoroacetate and trifluoroacetamide probes. Biochemistry. 28:1989;2378-2382.
30. 19F NMR probe of erythrocyte membrane potential. Eur Biophys J. 19:1991;327-334.
31. 19F-n.m.r. magnetization transfer. Biochem J. 266:1990;925-928.
32. 19F-NMR. Am J Physiol. 266:(4 Pt 2):1994;H1596-H1603.
33. 19F NMR chemical shift difference of fluorinated solutes in liposomes, erythrocytes and erythrocyte ghosts. NMR Biomed. 6:1993;136-143.
34. London RE. In vivo NMR studies utilizing fluorinated probes. Gillies RJ. MR in Physiology and Medicine. 1994;263-277 Academic Press, New York.
35. Jhun BH, Rampal AL, Berenski CJ, Jung CY. Chromatographic characterization of nitrobenzylthioinosine binding proteins in band 4.5 of human erythrocytes Purification of a 40 kDa truncated nucleoside transporter . Biochim Biophys Acta. 1028:1990;251-260.
36. 3H]dipyridamole with the nucleoside transporters of human erythrocytes and cultured animal cells. J Membr Biol. 98:1987;89-100.
37. Plagemann PGW. Transport and metabolism of adenosine in human erythrocytes Effect of transport inhibitors and regulation by phosphate . J Cell Physiol. 128:1986;491-500.
38. Gati WP, Paterson AR, Tyrrell DLJ, Cass CE, Moravek J, Robins MJ. Nucleobase transporter-mediated permeation of 2′,3′-dideoxyguanosine in human erythrocytes and human T-lymphoblastoid CCRF-CEM cells. J Biol Chem. 267:1992;22272-22276.
39. Mahony WB, Domin BA, Daluge SM, Miller WH, Zimmerman TP. Enantiomeric selectivity of carbovir transport. J Biol Chem. 267:1992;19792-19797.
40. Lieb WR, Stein WD. Simple diffusion across the membrane bilayer. Stein WD. Transport and Diffusion across Cell Membranes. 1986;69-112 Academic Press, San Diego.
41. Bevan C, Foulkes EC. Interaction of cadmium with brush border membrane vesicles from the rat small intestine. Toxicology. 54:1989;297-309.
42. Ives HE, Verkman AS. Effects of membrane fluidizing agents on renal brush border proton permeability. Am J Physiol. 249:1985;F933-F940.
43. Odoom JE, Campbell ID, Ellory JC, King GF. Characterization of peptide fluxes into human erythrocytes. A proton-n.m.r. study. Biochem J. 267:1990;141-147.
44. Gati WP, Knaus EE, Wiebe LI. Interaction of 2′-halogeno-2′-deoxyuridines with the human erythrocyte nucleoside transport mechanism. Mol Pharmacol. 23:1983;146-152.